HomeCompareBOBP vs CL

BOBP vs CL: Dividend Comparison 2026

BOBP yields 3.38% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CL wins by $15.9K in total portfolio value· pulled ahead in Year 2
10 years
BOBP
BOBP
● Live price
3.38%
Share price
$25.32
Annual div
$0.86
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$420.62
Full BOBP calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — BOBP vs CL

📍 CL pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBOBPCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BOBP + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BOBP pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BOBP
Annual income on $10K today (after 15% tax)
$287.58/yr
After 10yr DRIP, annual income (after tax)
$357.53/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CL beats the other by $4,234.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BOBP + CL for your $10,000?

BOBP: 50%CL: 50%
100% CL50/50100% BOBP
Portfolio after 10yr
$32.8K
Annual income
$2,911.29/yr
Blended yield
8.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

BOBP
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BOBP buys
0
CL buys
0
No recent congressional trades found for BOBP or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBOBPCL
Forward yield3.38%2.43%
Annual dividend / share$0.86$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$24.9K$40.8K
Annual income after 10y$420.62$5,401.96
Total dividends collected$3.8K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BOBP vs CL ($10,000, DRIP)

YearBOBP PortfolioBOBP Income/yrCL PortfolioCL Income/yrGap
1$11,038$338.33$11,012$312.01+$26.00BOBP
2← crossover$12,160$349.03$12,196$412.95$36.00CL
3$13,371$359.35$13,599$549.66$228.00CL
4$14,676$369.27$15,288$736.64$612.00CL
5$16,082$378.80$17,353$995.28$1.3KCL
6$17,596$387.94$19,926$1,357.80$2.3KCL
7$19,224$396.69$23,194$1,873.82$4.0KCL
8$20,975$405.04$27,439$2,621.52$6.5KCL
9$22,856$413.02$33,088$3,727.38$10.2KCL
10$24,876$420.62$40,806$5,401.96$15.9KCL

BOBP vs CL: Complete Analysis 2026

BOBPStock

BOBP invests in US large-cap securities identified to have favorable near- to medium-term capital appreciation potential based on equity skewness, a measure of how returns are likely to be higher or lower than average. Positive skewness suggests more frequent small losses and fewer but larger gains, while negative skewness implies more frequent small gains and fewer but larger losses. The index calculates equity skewness using a moving average and considers the correlation of each securitys return to its universe-wide average. If the universe-wide skewness is positive, the fund selects stocks with positive skewness. If the universe-wide skewness is negative, it favors stocks with less negative skewness. Based on these conditions, the fund selects and equally weights the top 50 stocks. The methodology aims to filter market noise and short-term volatility. The fund allocates 10-20% to cash and cash equivalents according to proprietary indicators. The index is rebalanced bi-weekly.

Full BOBP Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this BOBP vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BOBP vs SCHDBOBP vs JEPIBOBP vs OBOBP vs KOBOBP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.